|
1
|
Lauby-Secretan B, Scoccianti C, Loomis D,
Benbrahim-Tallaa L, Bouvard V, Bianchini F and Straif K:
International Agency for Research on Cancer Handbook Working Group:
Breast-cancer screening-viewpoint of the IARC Working Group. N Engl
J Med. 372:2353–2358. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu K, Wang J, Song Y, Zhao S, Liu H, Tang
D, Pan B, Zhao H and Zhang Q: miRNA-24-3p promotes cell
proliferation and inhibits apoptosis in human breast cancer by
targeting p27Kip1. Oncol Rep. 34:995–1002. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shi W, Bruce J, Lee M, Yue S, Rowe M,
Pintilie M, Kogo R, Bissey PA, Fyles A, Yip KW and Liu FF: MiR-449a
promotes breast cancer progression by targeting CRIP2. Oncotarget.
7:18906–18918. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin Z, Li JW, Wang Y, Chen T, Ren N, Yang
L, Xu W, He H, Jiang Y, Chen X, et al: Abnormal miRNA-30e
Expression is Associated with Breast Cancer Progression. Clin Lab.
62:121–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang HD, Sun DW, Mao L, Zhang J, Jiang
LH, Li J, Wu Y, Ji H, Chen W, Wang J, et al: MiR-139-5p inhibits
the biological function of breast cancer cells by targeting Notch1
and mediates chemosensitivity to docetaxel. Biochem Biophys Res
Commun. 465:702–713. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Long J, Ou C, Xia H, Zhu Y and Liu D:
MiR-503 inhibited cell proliferation of human breast cancer cells
by suppressing CCND1 expression. Tumour Biol. 36:8697–8702. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hoppe R, Achinger-Kawecka J, Winter S,
Fritz P, Lo WY, Schroth W and Brauch H: Increased expression of
miR-126 and miR-10a predict prolonged relapse-free time of primary
oestrogen receptor-positive breast cancer following tamoxifen
treatment. Eur J Cancer. 49:3598–3608. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pérez-Rivas LG, Jerez JM, Carmona R, de
Luque V, Vicioso L, Claros MG, Viguera E, Pajares B, Sánchez A,
Ribelles N, et al: A microRNA signature associated with early
recurrence in breast cancer. PLoS One. 9:e918842014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Khan S, Wall D, Curran C, Newell J, Kerin
MJ and Dwyer RM: MicroRNA-10a is reduced in breast cancer and
regulated in part through retinoic acid. BMC Cancer. 15:3452015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chang CH, Fan TC, Yu JC, Liao GS, Lin YC,
Shih AC, Li WH and Yu AL: The prognostic significance of RUNX2 and
miR-10a/10b and their inter-relationship in breast cancer. J Transl
Med. 12:2572014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pogribny IP, Filkowski JN, Tryndyak VP,
Golubov A, Shpyleva SI and Kovalchuk O: Alterations of microRNAs
and their targets are associated with acquired resistance of MCF-7
breast cancer cells to cisplatin. Int J Cancer. 127:1785–1794.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo Y, Chang H, Li J, Xu XY, Shen L, Yu ZB
and Liu WC: Thymosin alpha 1 suppresses proliferation and induces
apoptosis in breast cancer cells through PTEN-mediated inhibition
of PI3K/Akt/mTOR signaling pathway. Apoptosis. 20:1109–1121. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu R, Pan W, Fedulov AV, Jester W, Jones
MR, Weiss ST, Panettieri RA Jr, Tantisira K and Lu Q: MicroRNA-10a
controls airway smooth muscle cell proliferation via direct
targeting of the PI3Kinase pathway. FASEB J. 28:2347–2357. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kamal A, Nayak Lakshma V, Nagesh N,
Vishnuvardhan MV and Reddy Subba NV: Benzo [b]furan derivatives
induces apoptosis by targeting the PI3K/Akt/mTOR signaling pathway
in human breast cancer cells. Bioorg Chem. 66:124–131. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wani ZA, Guru SK, Rao AV, Sharma S,
Mahajan G, Behl A, Kumar A, Sharma PR, Kamal A, Bhushan S and
Mondhe DM: A novel quinazolinone chalcone derivative induces
mitochondrial dependent apoptosis and inhibits PI3K/Akt/mTOR
signaling pathway in human colon cancer HCT-116 cells. Food Chem
Toxicol. 87:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jia H, Zhang Z, Zou D, Wang B, Yan Y, Luo
M, Dong L, Yin H, Gong B, Li Z, et al: MicroRNA-10a is
down-regulated by DNA methylation and functions as a tumor
suppressor in gastric cancer cells. PLoS One. 9:e880572014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Renner O, Blanco-Aparicio C, Grassow M,
Canamero M, Leal JF and Carnero A: Activation of
phosphatidylinositol 3-kinase by membrane localization of p110alpha
predisposes mammary glands to neoplastic transformation. Cancer
Res. 68:9643–9653. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Egeland NG, Lunde S, Jonsdottir K, Lende
TH, Cronin-Fenton D, Gilje B, Janssen EA and Søiland H: The role of
MicroRNAs as predictors of response to tamoxifen treatment in
breast cancer patients. Int J Mol Sci. 16:24243–24275. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang SX, Polley E and Lipkowitz S: New
insights on PI3K/AKT pathway alterations and clinical outcomes in
breast cancer. Cancer Treat Rev. 45:87–96. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Suen DF, Norris KL and Youle RJ:
Mitochondrial dynamics and apoptosis. Genes Dev. 22:1577–1590.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Breckenridge DG and Xue D: Regulation of
mitochondrial membrane permeabilization by BCL-2 family proteins
and caspases. Curr Opin Cell Biol. 16:647–652. 2004. View Article : Google Scholar : PubMed/NCBI
|
